Cresco Labs Inc.
CL
CNSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.40% | -2.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.40% | -2.26% | |||
| Cost of Revenue | -5.18% | 6.41% | |||
| Gross Profit | -7.76% | -10.39% | |||
| SG&A Expenses | 3.72% | -4.18% | |||
| Depreciation & Amortization | -5.52% | -4.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.97% | 1.92% | |||
| Operating Income | -37.51% | -24.13% | |||
| Income Before Tax | -130.05% | -73.02% | |||
| Income Tax Expenses | 447.25% | -86.24% | |||
| Earnings from Continuing Operations | -3,570.16% | 105.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 116.67% | -68.98% | |||
| Net Income | -230.10% | 58.52% | |||
| EBIT | -37.51% | -24.13% | |||
| EBITDA | -25.68% | -18.22% | |||
| EPS Basic | -226.98% | 58.42% | |||
| Normalized Basic EPS | 114.93% | -141.88% | |||
| EPS Diluted | -226.98% | 58.42% | |||
| Normalized Diluted EPS | 114.93% | -141.88% | |||
| Average Basic Shares Outstanding | 0.66% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.66% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||